Cargando…
CD276 (B7H3) improve cancer stem cells formation in cervical carcinoma cell lines
BACKGROUND: Cancer stem cells (CSCs) have been considered as a potential therapeutic target for cervical carcinoma. CD 276 is a well-known immune check point molecular, but its relationship with cervical CSCs was still unclear. METHODS: HeLa cell lines were obtained as cervical carcinoma in vitro mo...
Autores principales: | Shi, Jianfeng, Zhao, Haishan, Lian, Huan, Ke, Linnan, Zhao, Lei, Wang, Chunren, Han, Qianqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798926/ https://www.ncbi.nlm.nih.gov/pubmed/35116240 http://dx.doi.org/10.21037/tcr-19-2910 |
Ejemplares similares
-
In vitro genotoxicity evaluation and metabolic study of residual glutaraldehyde in animal-derived biomaterials
por: Shi, Jianfeng, et al.
Publicado: (2020) -
B7-H3/CD276: An Emerging Cancer Immunotherapy
por: Zhou, Wu-Tong, et al.
Publicado: (2021) -
Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation
por: Harland, Niklas, et al.
Publicado: (2022) -
Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
por: Inamura, Kentaro, et al.
Publicado: (2018) -
B7-H3/CD276 Inhibitors: Is There Room for the Treatment of Metastatic Non-Small Cell Lung Cancer?
por: Malapelle, Umberto, et al.
Publicado: (2022)